Table 1.
Demographic characteristics and inflammatory markers on hospital days 1 and 2 among patients with COVID-19 with (BMI≥30) and without obesity (BMI<30), Boston, MA (n = 791).
Table 2.
Univariate and multivariate analyses of comorbidities, inflammatory markers on day 1, maximum FiO2, and IL-6 inhibitor use in relationship to ICU transfer.
Fig 1.
Median, IQR, and range of inflammatory markers and absolute lymphocyte count on hospital days 1 and 2 as well as maximum FiO2 during hospitalization by body mass index (BMI) group.
CRP = C reactive protein, LDH = lactate dehydrogenase ALC = absolute lymphocyte count. * = 0.01 < p < 0.05, ** = p<0.01.
Table 3.
Inflammatory markers and absolute lymphocyte count on hospital day 1 and maximum FiO2 required during hospitalization grouped by presence of obesity and diabetes.